Bionano Genomics (BNGO) Accumulated Expenses (2017 - 2026)

Bionano Genomics' Accumulated Expenses history runs 10 years deep, the most recent figure standing at $629000.0 for Q1 2026.

• In Q1 2026, Accumulated Expenses fell 84.02% year-over-year to $629000.0; the TTM figure through Mar 2026 stood at $629000.0 (down 84.02% YoY), while the FY2025 annual figure was $561000.0, down 71.71% from the prior year.
• Accumulated Expenses came in at $629000.0 for Q1 2026 at Bionano Genomics, up from $561000.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $11.7 million in Q3 2022 to a low of $561000.0 in Q4 2025.
• A 5-year average of $6.7 million and a median of $7.8 million in 2022 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses jumped 91.8% in 2022 and sank 84.02% in 2026, its largest moves.
• Bionano Genomics' Accumulated Expenses stood at $10.6 million in 2022, then dropped by 23.34% to $8.1 million in 2023, then tumbled by 75.49% to $2.0 million in 2024, then tumbled by 71.71% to $561000.0 in 2025, then climbed by 12.12% to $629000.0 in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $629000.0, $561000.0, and $4.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison